OnDosis is developing an intelligent drug delivery platform centered on a handheld dosing device that delivers tailored doses of oral medicines. The device can connect to a wider range of digital health technologies, such as remote dose control and adherence monitoring, opening up numerous opportunities to improve treatment outcomes.
Impact: Flexible and individualized dosing of oral medicines formulated as micro units, ultimately leading to improving health care outcomes.
CEO: Martin Olovsson
GUV Contact: Jan Pilebjer